Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12609000617268Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of amoxicillin in edentulism (4 arms), sponsored by ITI Foundation. Primary endpoints: Patient-centered outcomes by visual analogue scale and Presence of surgical complications. Planned start Sep 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12609000617268.